# DYDX

> DYDX is a VC fund in Newport Beach backing Biotechnology, AgTech and Cannabis. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Newport Beach, United States
- Total investments: 6
- Last investment: May 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/dydx-capital/
- Website: https://dydxcap.com/

DYDX is a VC fund in Newport Beach focused on Biotechnology and AgTech. DYDX Capital is a venture capital firm that invests in companies that use data to solve problems.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 33% |
| AgTech | 1 | 17% |
| Cannabis | 1 | 17% |
| Agriculture | 1 | 17% |
| Pharmaceutical | 1 | 17% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Series B | 1 | 17% |
| Funding Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 50% |
| New Zealand | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tribal | Tribal can triage, correct, create, or return the work with complete context because it already has a thorough understanding of your organization, including every object, field, dependency, and permission. | $10M | Seed | May 20, 2026 |  |
| TESS | Founded in California by Brazilian entrepreneurs, TESS AI is an enterprise-grade autonomous agentic AI platform engineered to deliver hard corporate ROI. The company empowers professionals to build highly customized AI agents orchestrating over 250 AI models, featuring native integration with global automation ecosystems. By pioneering adisruptive, "seatless" pricing model, TESS eliminates restrictive per-user licenses, generating up to 90% in cost savings and allowing enterprises to consolidate their stack by replacing 4 to 5 traditional SaaS tools within the first six months. Powered by a complex agentic architecture—outperforming Meta’s $2B Manus AI—TESS is driving explosive adoption, with over 16,000 users executing more than 600,000 autonomous tasks every month. | $4.9M | Seed | Mar 02, 2026 |  |
| Immuto Scientific | Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery. | $8M | Seed | Sep 18, 2025 |  |
| Bruviti | Bruviti is an enterprise AI platform that uses AI & Ml to to connect with customers, deliver exceptional service and complete the most critical feedback loop to accelerate repeat buys, increase accessory sales and improved margins. Bruviti's proprietary decision fabric engine enables companies to make smarter, faster, data-driven decisionsby providing predictive, actionable service recommendations. Bruviti is addressing 500B+ equipment service market that is going to define next generation of Customer Service Experience. | $6M |  | Aug 07, 2025 |  |
| Bruviti | Bruviti is an enterprise AI platform that uses AI & Ml to to connect with customers, deliver exceptional service and complete the most critical feedback loop to accelerate repeat buys, increase accessory sales and improved margins. Bruviti's proprietary decision fabric engine enables companies to make smarter, faster, data-driven decisionsby providing predictive, actionable service recommendations. Bruviti is addressing 500B+ equipment service market that is going to define next generation of Customer Service Experience. | $6M |  | Aug 07, 2025 |  |
| BioLumic | BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements incrops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013. | $8.3M | Series B | Apr 22, 2025 |  |

6 of 6 investments shown.

## Co-investors
- [Arka Venture Labs](https://shizune.co/investors/profile/arka-ventures-labs) — VC Fund, 2 deals together
- [Moment Ventures](https://shizune.co/investors/profile/moment-ventures) — VC Fund, 2 deals together
- [Nivesha Ventures](https://shizune.co/investors/profile/nivesha-ventures) — VC Fund, 2 deals together
- [Pranatech Venture Capital](https://shizune.co/investors/profile/pranatech-venture-capital) — VC Fund, 2 deals together
- [Startup Capital Ventures x SBI Fund](https://shizune.co/investors/profile/startup-capital-ventures-x-sbi-fund) — VC Fund, 2 deals together
- [Hi Ventures](https://shizune.co/investors/profile/venture-partners-2) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does DYDX invest in?

DYDX invests primarily in Biotechnology, AgTech and Cannabis startups, most often at Seed and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did DYDX last invest?

The most recent investment recorded for DYDX closed in May 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co